Merck Sharp & Dohme Research Labs
Executive Summary
Charles Leighton to senior VP-medical and regulatory affairs, assuming added responsibility for medical affairs; W. John Powell to VP-clinical research; Eve E. Slater to executive director clinical and regulatory development.